Evaluation of a Dry Powder Aerosol Dispersion Mechanism by Radiolabeling Techniques

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Adult Healthy Volunteers
Interventions
DEVICE

modified Handihaler DPI

subjects randomized to receive 1 inhaled dose on 2 separate days, each dose delivered 2-3 days apart. The radiolabeled albuterol drug powder will be dispersed from either the DET bead-HandiHaler prototype or via the established HandiHaler device standard with the lactose-albuterol formulation provided to us by the sponsor.

DEVICE

standard Handihaler DPI

subjects randomized to receive 1 inhaled dose on 2 separate days, each dose delivered 2-3 days apart. The radiolabeled albuterol drug powder will be dispersed from either the DET bead-HandiHaler prototype or via the established HandiHaler device standard with the lactose-albuterol formulation provided to us by the sponsor.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, CEMALB, Chapel Hill

All Listed Sponsors
collaborator

University of Texas at Austin

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT01495442 - Evaluation of a Dry Powder Aerosol Dispersion Mechanism by Radiolabeling Techniques | Biotech Hunter | Biotech Hunter